Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
We recently identified three sub-populations of refractory acute myeloid leukemia (AML) patients with distinct intrinsic resistance mechanisms. Furthermore, we were able to risk-stratify the overall survival of the patients and identify patients who would likely benefit from alternative therapies.
Main Author: | Sachi Horibata |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-11-01
|
Series: | Molecular & Cellular Oncology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/23723556.2019.1650631 |
Similar Items
-
Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia
by: Stefan Hatzl, et al.
Published: (2020-02-01) -
Investigation of Biomarkers Associated with Low Platelet Counts in Normal Karyotype Acute Myeloid Leukemia
by: Chang-Hun Park, et al.
Published: (2022-07-01) -
Single-Cell Transcriptome Analysis of Acute Myeloid Leukemia Cells Using Methanol Fixation and Cryopreservation
by: Lamia Madaci, et al.
Published: (2023-12-01) -
Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia
by: Yanan Zhai, et al.
Published: (2022-08-01) -
Molecular Profiling of Kenyan Acute Myeloid Leukemia Patients
by: Mercy Gatua, et al.
Published: (2022-06-01)